-
公开(公告)号:US10166228B2
公开(公告)日:2019-01-01
申请号:US15961201
申请日:2018-04-24
发明人: Harry G. Brittain , David A. Dickason , Joyce M. Hotz , Shawn L. Lyons , J. Michael Ramstack , Steven G. Wright
IPC分类号: A61K31/485 , C07D489/08 , C07D489/06 , C07C19/03
摘要: This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof. These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations.
-
公开(公告)号:US20190167664A1
公开(公告)日:2019-06-06
申请号:US16201067
申请日:2018-11-27
发明人: Harry G. Brittain , David A. Dickason , Joyce M. Hotz , Shawn L. Lyons , J. Michael Ramstack , Steven G. Wright
IPC分类号: A61K31/485 , C07C19/03 , C07D489/08 , C07D489/06
CPC分类号: A61K31/485 , C07B2200/13 , C07C19/03 , C07D489/06 , C07D489/08
摘要: This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof. These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations.
-
公开(公告)号:US09980958B2
公开(公告)日:2018-05-29
申请号:US15794365
申请日:2017-10-26
发明人: Harry G. Brittain , David A. Dickason , Joyce M. Hotz , Shawn L. Lyons , J. Michael Ramstack , Steven G. Wright
IPC分类号: A61K31/485 , C07D489/06 , C07D489/08
CPC分类号: A61K31/485 , C07B2200/13 , C07C19/03 , C07D489/06 , C07D489/08
摘要: This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof. These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations.
-
公开(公告)号:US09827240B2
公开(公告)日:2017-11-28
申请号:US15381581
申请日:2016-12-16
发明人: Harry G. Brittain , David A. Dickason , Joyce M. Hotz , Shawn L. Lyons , J. Michael Ramstack , Steven G. Wright
IPC分类号: A61K31/485 , C07D489/06 , C07D489/08
CPC分类号: A61K31/485 , C07B2200/13 , C07C19/03 , C07D489/06 , C07D489/08
摘要: This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof. These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations.
-
公开(公告)号:US20160362415A1
公开(公告)日:2016-12-15
申请号:US15175399
申请日:2016-06-07
发明人: Harry G. Brittain , David A. Dickason , Joyce M. Hotz , Shawn L. Lyons , J. Michael Ramstack , Steven G. Wright
IPC分类号: C07D489/02
CPC分类号: A61K31/485 , C07B2200/13 , C07C19/03 , C07D489/06 , C07D489/08
摘要: This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof. These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations.
摘要翻译: 本发明涉及纳曲酮的新型多晶型物的发现,包括溶剂合物,水合物,无水和其它结晶形式及其组合。 纳曲酮的这些新型形式赋予其掺入它们的药物制剂中的优点,包括持续释放或长效制剂。
-
公开(公告)号:US20180303825A1
公开(公告)日:2018-10-25
申请号:US15961201
申请日:2018-04-24
发明人: Harry G. Brittain , David A. Dickason , Joyce M. Hotz , Shawn L. Lyons , J. Michael Ramstack , Steven G. Wright
IPC分类号: A61K31/485 , C07C19/03 , C07D489/08 , C07D489/06
CPC分类号: A61K31/485 , C07B2200/13 , C07C19/03 , C07D489/06 , C07D489/08
摘要: This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof. These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations.
-
公开(公告)号:US09365580B2
公开(公告)日:2016-06-14
申请号:US14945607
申请日:2015-11-19
发明人: Harry G. Brittain , David A. Dickason , Joyce M. Hotz , Shawn L. Lyons , J. Michael Ramstack , Steven G. Wright
IPC分类号: A61K31/485 , C07D489/08 , C07C19/03
CPC分类号: A61K31/485 , C07B2200/13 , C07C19/03 , C07D489/06 , C07D489/08
摘要: This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations.
摘要翻译: 本发明涉及纳曲酮的新型多晶型物的发现,包括溶剂化物,水合物,无水和其它结晶形式及其组合。纳他酮的这些新型形式在掺入其中的药物制剂中赋予其优势,包括持续释放或长效制剂。
-
8.
公开(公告)号:US20140193507A1
公开(公告)日:2014-07-10
申请号:US14085051
申请日:2013-11-20
CPC分类号: A61K47/34 , A61K9/0019 , A61K9/1641 , A61K9/1647 , A61K9/1658 , A61K31/505 , A61K47/26 , A61K47/38
摘要: Injectable compositions having improved injectability. The injectable compositions include microparticles suspended in an aqueous injection vehicle having a viscosity of at least 20 cp at 20° C. The increased viscosity of the injection vehicle that constitutes the fluid phase of the suspension significantly reduces in vivo injectability failures. The injectable compositions can be made by mixing dry microparticles with an aqueous injection vehicle to form a suspension, and then mixing the suspension with a viscosity enhancing agent to increase the viscosity of the fluid phase of the suspension to the desired level for improved injectability.
摘要翻译: 具有改进的注射性的可注射组合物。 可注射组合物包括悬浮在20摄氏度粘度至少为20cp的含水注射用载体中的微粒。构成悬浮液相的注射载体的增加的粘度显着降低体内注射性失败。 可注射组合物可以通过将干燥微粒与水性注射载体混合以形成悬浮液,然后将悬浮液与粘度增强剂混合以将悬浮液的流体相的粘度增加至所需水平以改善注射性,从而制备。
-
公开(公告)号:US20180110773A1
公开(公告)日:2018-04-26
申请号:US15794365
申请日:2017-10-26
发明人: Harry G. Brittain , David A. Dickason , Joyce M. Hotz , Shawn L. Lyons , J. Michael Ramstack , Steven G. Wright
IPC分类号: A61K31/485 , C07D489/08 , C07D489/06
CPC分类号: A61K31/485 , C07B2200/13 , C07C19/03 , C07D489/06 , C07D489/08
摘要: This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof. These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations.
-
公开(公告)号:US09556189B2
公开(公告)日:2017-01-31
申请号:US15175399
申请日:2016-06-07
发明人: Harry G. Brittain , David A. Dickason , Joyce M. Hotz , Shawn L. Lyons , J. Michael Ramstack , Steven G. Wright
IPC分类号: A61K31/485 , C07D489/08 , C07C19/03 , C07D489/06
CPC分类号: A61K31/485 , C07B2200/13 , C07C19/03 , C07D489/06 , C07D489/08
摘要: This invention relates to the discovery of novel polymorphic forms of naltrexone, including solvates, hydrates, anhydrous and other crystalline forms and combinations thereof. These novel forms of naltrexone impart advantages in pharmaceutical formulations incorporating them, including sustained release, or long acting, formulations.
摘要翻译: 本发明涉及纳曲酮的新型多晶型物的发现,包括溶剂合物,水合物,无水和其它结晶形式及其组合。 纳曲酮的这些新型形式赋予其掺入它们的药物制剂中的优点,包括持续释放或长效制剂。
-
-
-
-
-
-
-
-
-